The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Regulatory News (STX)

Share Price Information for Shield Thera (STX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.00
Bid: 1.90
Ask: 2.10
Change: 0.10 (5.26%)
Spread: 0.20 (10.526%)
Open: 1.90
High: 2.00
Low: 1.95
Prev. Close: 1.90
STX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

24 Jul 2023 14:27

RNS Number : 9974G
Shield Therapeutics PLC
24 July 2023
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BYV81293

Issuer Name

SHIELD THERAPEUTICS PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Jupiter Fund Management PLC

City of registered office (if applicable)

London

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Name

City of registered office

Country of registered office

Northern Trust

5. Date on which the threshold was crossed or reached

21-Jul-2023

6. Date on which Issuer notified

24-Jul-2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

4.780000

0.000000

4.780000

34127697

Position of previous notification (if applicable)

6.700000

0.000000

6.700000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BYV81293

34127697

4.780000

Sub Total 8.A

34127697

4.780000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Jupiter Fund Management Plc ( Chain 1)

0.000000

0.000000

0.000000%

Jupiter Fund Management Plc ( Chain 1)

Jupiter Fund Management Group Limited

0.000000

0.000000

0.000000%

Jupiter Fund Management Plc ( Chain 1)

Jupiter Asset Management Group Limited

0.000000

0.000000

0.000000%

Jupiter Fund Management Plc ( Chain 1)

Knightsbridge Asset Management Limited

0.000000

0.000000

0.000000%

Jupiter Fund Management Plc ( Chain 1)

Jupiter Investment Management Group Limited

0.000000

0.000000

0.000000%

Jupiter Fund Management Plc ( Chain 1)

Jupiter Asset Management Limited

4.780000

0.000000

4.780000%

Jupiter Fund Management Plc (Chain 2)

Merian Global Investors Limited

0.000000

0.000000

0.000000%

Jupiter Fund Management Plc (Chain 2)

Merian Global Investors (Jersey) Limited

0.000000

0.000000

0.000000%

Jupiter Fund Management Plc (Chain 2)

Merian Global Investors (Finance) Limited

0.000000

0.000000

0.000000%

Jupiter Fund Management Plc (Chain 2)

Merian Global Investors Holdings Limited

0.000000

0.000000

0.000000%

Jupiter Fund Management Plc (Chain 2)

Jupiter Investment Management Limited

0.000000

0.000000

0.000000%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

24.07.2023

13. Place Of Completion

London, UK

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLRIMJTMTTTBAJ
Date   Source Headline
31st Mar 20213:01 pmRNSTotal Voting Rights Update
31st Mar 20213:00 pmRNSBlock Listing 6 Monthly Return
30th Mar 20217:00 amRNSInvestor presentation
26th Mar 20217:00 amRNSStudy demonstrates effectiveness of ferric maltol
24th Mar 20215:40 pmRNSBlock Listing Application
23rd Mar 20215:53 pmRNSHolding(s) in Company
23rd Mar 202112:23 pmRNSHolding(s) in Company
22nd Mar 20217:00 amRNSShield appoints new Chief Financial Officer
18th Mar 20212:02 pmRNSResult of General Meeting & Open Offer
15th Mar 20215:21 pmRNSHolding(s) in Company
9th Mar 20217:00 amRNSAustralia's TGA approves Feraccru
5th Mar 20214:54 pmRNSPDMR Transaction Notification
4th Mar 20216:17 pmRNSPDMR/PCA Transaction Notification
3rd Mar 20211:40 pmRNSInvestor Presentation
1st Mar 20217:00 amRNSPublication of Circular and Notice of GM
26th Feb 20214:09 pmRNSSuccessful completion of £25 million Fundraise
26th Feb 202112:30 pmRNSTotal Voting Rights Update
26th Feb 202111:05 amRNSSecond Price Monitoring Extn
26th Feb 202111:00 amRNSPrice Monitoring Extension
26th Feb 20219:30 amRNSPlacing and Subscription to raise up to £25m
19th Feb 202111:05 amRNSSecond Price Monitoring Extn
19th Feb 202111:00 amRNSPrice Monitoring Extension
2nd Feb 20218:00 amEQSEdison Investment Research Limited: Shield Therapeutics (STX): Beefing up for the US opportunity
29th Jan 20212:38 pmRNSShareholder loan facilities
29th Jan 20217:00 amRNSTotal Voting Rights Update
21st Jan 20215:41 pmRNSDirector/PDMR Shareholding
19th Jan 20212:20 pmRNSDirector/PDMR Shareholding
15th Jan 202110:00 amRNSInvestor presentation
15th Jan 20217:00 amRNSBusiness and trading update
14th Jan 202111:05 amRNSSecond Price Monitoring Extn
14th Jan 202111:00 amRNSPrice Monitoring Extension
6th Jan 20217:15 amEQSHardman & Co Research: Shield Therapeutics (STX): Reassessing the US opportunity
31st Dec 20207:00 amRNSTotal Voting Rights Update
22nd Dec 202010:06 amRNSHolding(s) in Company
21st Dec 20207:00 amRNSInvestor Presentation
18th Dec 20205:21 pmRNSGrant of share options to the CEO
18th Dec 20205:15 pmRNSPDMR Exercise of Share Options
14th Dec 20207:00 amRNSDirector/PDMR Shareholding
14th Dec 20207:00 amRNSInvestor Presentation
10th Dec 202011:05 amRNSSecond Price Monitoring Extn
10th Dec 202011:00 amRNSPrice Monitoring Extension
10th Dec 20207:00 amRNSUpdate re US partnering discussions
30th Nov 20207:00 amRNSHolding(s) in Company
30th Nov 20207:00 amRNSTotal Voting Rights Update
2nd Nov 20207:00 amRNSTotal Voting Rights Update
19th Oct 20207:00 amRNSWithdrawal of all oppositions by TEVA
30th Sep 20201:21 pmRNSBlock Listing 6 Monthly Return
30th Sep 20201:20 pmRNSTotal Voting Rights Update
18th Sep 20201:30 pmEQSHardman & Co Research: Shield Therapeutics (STX): Optimism over US deal
16th Sep 20207:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.